Recro Pharma: 3Q Earnings Snapshot
MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Wednesday reported a loss of $13.3 million in its third quarter.
The Malvern, Pennsylvania-based company said it had a loss of 64 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 67 cents per share.
The specialty pharmaceutical company posted revenue of $18.3 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $16.8 million.
Recro Pharma shares have decreased 25 percent since the beginning of the year. The stock has decreased 21 percent in the last 12 months.